| 2024-10-18 | Pertussis infections rising | Vaccine-preventable diseases |
| 2024-10-04 | Fall 2024 COVID-19 vaccine guidance | Vaccine-preventable diseases |
| 2024-09-20 | Universal Influenza Immunization Program implementation for the 2024-2025 season | Vaccine-preventable diseases |
| 2024-09-09 | Human Case of Rabies in Ontario | Infectious diseases |
| 2024-08-29 | 2024-2025 high-risk older adult respiratory syncytial virus program | Vaccine-preventable diseases |
| 2024-08-29 | 2024-2025 infant and high-risk children RSV prevention program | Vaccine-preventable diseases |
| 2024-08-29 | Market withdrawal of COVID-19 XBB vaccines in Canada | Vaccine-preventable diseases |
| 2024-07-19 | 2024-2025 High-Risk Older Adult Respiratory Syncytial Virus Program
Fact Sheet for Health Care Providers (English) (PDF, 240 KB)
Fact Sheet for Health Care Providers (French) (PDF, 276 KB)
Fact Sheet for Vaccine Recipients (English) (PDF, 178 KB)
Fact Sheet for Vaccine Recipients (French) (PDF, 205 KB)
Letter to Retirement Home Operators and Licensees (English) (PDF, 360 KB)
Letter to Retirement Home Operators and Licensees (French) (PDF, 349 KB)
Letter to Long-Term Care Home Medical Directors (English) (PDF, 361 KB)
Letter to Long-Term Care Home Medical Directors (French) (PDF, 350 KB) | Vaccine-preventable diseases |
| 2024-07-18 | Increasing pertussis infections: assessment and immunization | Vaccine-preventable diseases |
| 2024-07-09 | Pneumococcal vaccine program transition
Health Care Provider Fact Sheet: Pneumococcal Conjugate Vaccines for Children Aged 6 Weeks to 4 Years (PDF, 472 KB)
Fiche de renseignements à l’intention des professionnels de la santé : Vaccins antipneumococciques conjugués pour les
enfants âgés de 6 semaines à 4 ans (PDF, 363 KB)
Health Care Provider Fact Sheet: Pneumococcal Conjugate Vaccine for Individuals Aged 5 to 64 Years at High Risk for Invasive Pneumococcal Disease (PDF, 503 KB)
Fiche de renseignements à l’intention des
professionnels de la santé : Vaccin antipneumococcique conjugué pour les personnes âgées de 5 à 64 ans présentant un risque élevé de pneumococcie invasive (PDF, 320 KB)
Health Care Provider Fact Sheet: Pneumococcal Conjugate Vaccine for Individuals Aged 65 Years and Older (PDF, 1 MB)
Fiche de renseignements à l’intention des professionnels de la santé : Vaccin antipneumococcique conjugué pour les personnes âgées de 65 ans et plus (PDF, 364 KB)
Qs & As for Health Care Providers: Pneumococcal Vaccine Transition (PDF, 374 KB)
Questions et réponses à l’intention des professionnels de la santé : Adoption de nouveaux vaccins antipneumococciques (PDF, 260 KB) | Vaccine-preventable diseases |
| 2024-06-06 | Blastomycosis: Key information for health care practitioners | Infectious diseases |
| 2024-06-04 | Enhancing protection from poliovirus: Updated polio vaccine recommendations for children new to Canada | Vaccine-preventable diseases |
| 2024-05-22 | 2024-2025 Universal Influenza Immunization Program Application Process | Vaccine-preventable diseases |
| 2024-05-17 | Public Health Ontario Webinar: Measles Update for Clinicians and Public Health | Vaccine-preventable diseases |
| 2024-05-09 | Changes to Tuberculosis Skin Testing clinic services | Infectious diseases |
| 2024-04-08 | Transition to Pentacel® from Pediacel® vaccine in the publicly funded immunization program
Pentacel Product Monograph (English) (PDF, 792 KB)
Pentacel Product Monograph (French) (PDF, 576 KB) | Vaccine-preventable diseases |
| 2024-03-22 | COVID-19 vaccine guidance for spring 2024 and wind-down of RSV fall 2023 high-risk program | Vaccine-preventable diseases |
| 2024-03-21 | Important measles information for health care providers | Vaccine-preventable diseases |
| 2024-03-06 | Nicotine pouches | Substance use |
| 2024-03-01 | Student vaccine requirements under the Immunization of School Pupils Act | Vaccine-preventable diseases |
| 2024-02-23 | Update: Changes to Rabies Animal Incident Reporting Form | Infectious diseases |
| 2024-02-09 | Medetomidine/dexmedetomidine confirmed in Ontario | Overdose prevention |
| 2024-02-09 | Re-emergence of vaccine preventable diseases | Vaccine-preventable diseases |
| 2024-01-30 | Infectious syphilis cases increasing locally and CME/CPD opportunity
CME Opportunity – Northern Knowledge Exchange Rounds email advertisement (PDF, 220 KB) | Sexual health |
| 2023-12-18 | Increased Invasive Group A Streptococcal Disease in Ontario
Memo to hospitals and healthcare providers re increased iGAS (English) (PDF, 490 KB)
Memo to hospitals and healthcare providers re increased iGAS (French) (PDF, 73 KB) | Infectious diseases |
| 2023-12-15 | Expanded eligibility for the publicly funded respiratory syncytial virus vaccine program | Vaccine-preventable diseases |
| 2023-12-05 | Update: Changes to Ontario Public Health Standards webpage and the Botulism Guide for Health Care Professionals | Infectious diseases |
| 2023-11-07 | Implementation of the publicly funded respiratory syncytial virus vaccine program | Vaccine-preventable diseases |
| 2023-11-01 | Important information regarding the publicly funded high-risk respiratory syncytial virus vaccine program | Vaccine-preventable diseases |
| 2023-10-05 | COVID-19 vaccine guidance for the fall 2023 | Vaccine-preventable diseases |
| 2023-09-18 | Universal Influenza Immunization Program implementation for the 2023-24 season | Vaccine-preventable diseases |
| 2023-09-15 | Pediatric Infectious Disease and the Fall Respiratory Season | Vaccine-preventable diseases |
| 2023-07-11 | Updated COVID-19 vaccine guidance and vaccination opportunities offered by Public Health Sudbury & Districts | Vaccine-preventable diseases |
| 2023-06-30 | Anaplasmosis, babesiosis, and Powassan virus must now be reported to Medical Officer of Health | Infectious-diseases |
| 2023-06-29 | Discontinuation of Janssen COVID-19 vaccines in Canada | Vaccine-preventable diseases |
| 2023-05-25 | Increased Invasive Group A Streptococcal Disease in Ontario | Infectious-diseases |
| 2023-05-16 | Reminder to report adverse events following immunization | Vaccine-preventable diseases |
| 2023-05-12 | Multi-drug resistant gonorrhea update
Detection of ceftriaxone non-susceptible Neisseria gonorrhoeae in Ontario (PDF, 712 KB) | Sexual health |
| 2023-05-11 | 2023–2024 Universal Influenza Immunization Program application process | Vaccine-preventable diseases |
| 2023-04-20 | Infectious syphilis cases increasing locally (PDF, 292 KB) | Sexual health |
| 2023-04-17 | Important immunization reminders | Vaccine-preventable diseases |
| 2023-04-06 | COVID-19 vaccine spring booster recommendations | Vaccine-preventable diseases |
| 2023-04-04 | Multi-drug resistant gonorrhea identified
Ministry of Health memo on multi-drug resistant gonorrhea (PDF, 100 KB) | Sexual health |
| 2023-03-29 | New Ontario guidelines for providers offering HIV testing
English (PDF, 541 KB)
Ontario guidelines for providers offering HIV testing
French (PDF, 550 KB)
Lignes directrices ontariennes à l’intention des prestataires de soins qui offrent le dépistage du VIH | Infectious-diseases |
| 2023-03-20 | Mpox in 2023: Information for clinicians | Vaccine-preventable diseases |
| 2023-03-17 | XDR Shigella
Memo for further information on XDR Shigella (PDF, 206 KB) | Infectious-diseases |
| 2023-03-10 | Supply of erythromycin ophthalmic ointment and the importance of adhering to the legislation | Vaccine-preventable diseases |
| 2023-03-09 | Changes to Lyme disease testing | Infectious-diseases |
| 2023-02-24 | Respiratory and enteric testing supplies | Infection prevention and control |
| 2023-02-22 | Measles preparedness | Infectious-diseases |
| 2023-02-21 | Xylazine/’Tranq’ confirmed locally | Substance use |
| 2023-01-13 | Public Health Sudbury & Districts’ hours of operation | Public Health Services |
| 2023-01-11 | Vaccination requirements for school attendance | Vaccine-preventable diseases |
| 2022-12-20 | COVID-19 vaccine program update | Vaccine-preventable diseases |
| 2022-11-29 | Influenza vaccine availability | Vaccine-preventable diseases |
| 2022-11-10 | COVID-19 vaccine update: Guidance on the use of Pfizer BioNTech Comirnaty in immunocompromised children
Flow diagram for COVID-19 fall booster vaccination (PDF, 453 KB) | Vaccine-preventable diseases |
| 2022-10-18 | COVID-19 vaccine update: Bivalent vaccines (Pfizer and Moderna) now both available in Sudbury and Manitoulin districts | Vaccine-preventable diseases |
| 2022-10-13 | Updated monkeypox vaccination guidance | Infectious-diseases |
| 2022-10-05 | Rowan’s Law (concussion safety): Removal-from-sport and return-to-sport protocol requirements | Concussions
|
| 2022-09-27 | COVID-19 vaccine update: Monovalent Pfizer-BioNTech Comirnaty for children aged 6 months to under 5 years available in Sudbury and Manitoulin districts | Vaccine-preventable diseases |
| 2022-09-23 | Recognize and report cases of Acute Flaccid Paralysis | Vaccine-preventable diseases |
| 2022-09-12 | COVID-19 vaccine update: Bivalent Moderna vaccine available in Sudbury and Manitoulin districts | Vaccine-preventable diseases |
| 2022-09-12 | Influenza vaccine availability for the 2022/2023 season
UIIP package attachments | Vaccine-preventable diseases |
| 2022-09-02 | Health Care Providers and Public Health Units: Memorandum regarding Aconitine poisoning | Food-safety |
| 2022-09-01 | COVID-19 vaccine update: Approval of first booster dose for individuals aged 5-11 | Vaccine-preventable diseases |
| 2022-09-01 | Updated monkeypox vaccination and antiviral guidance | Infectious-diseases |
| 2022-07-28 | Suspension: Vaccine pick up | Vaccine-preventable diseases |
| 2022-07-27 | COVID-19 vaccine update: Immunocompromised individuals aged 12 to 17 eligible for second booster dose AND Moderna Spikevax vaccine available for children aged 6 months to 5 years | Vaccine-preventable diseases |
| 2022-07-26 | Monkeypox PrEP immunization offered to eligible individuals | Infectious-diseases |
| 2022-07-14 | COVID-19 vaccine update: Expansion of second booster dose eligibility to include all individuals aged 18 and over | Vaccine-preventable diseases |
| 2022-07-12 | Updated monkeypox treatment guidance and other key resources
Comparison chart MPX vs VZV vs HFMD_June 2022 (PDF, 637 KB) | Infectious-diseases |
| 2022-06-22 | Treatment for Infectious Syphilis | Sexual health |
| 2022-06-20 | Monkeypox now reportable to Medical Officer of Health as a newly designated disease of Public Health significance under Provincial legislation
Factsheet: Smallpox and other orthopoxviruses including monkeypox (Ontario Public Health Standards) (PDF, 2.77 MB)
Memorandum: Health Care Providers and Public Health Units RE: Monkeypox (Ministry of Health) (PDF, 52 KB) | Vaccine-preventable diseases |
| 2022-06-14 | National hypoallergenic infant formula shortage | National Hypoallergenic Infant Formula Shortage |
| 2022-06-08 | Updated guidance for routine immunization services during COVID-19 | Vaccine-preventable diseases |
| 2022-05-31 | Interim guidance for post-exposure prophylaxis and treatment of monkeypox
| Infectious-diseases |
| 2022-05-21 | Reports of confirmed monkeypox in Canada
| Infectious-diseases |
| 2022-05-11 | Co-circulation of seasonal influenza and SARS-CoV-2 – Considerations for outbreak identification and management | Vaccine-preventable diseases |
| 2022-05-05 | Increased eligibility for two publicly funded vaccines
| Vaccine-preventable diseases |
| 2022-05-05 | COVID-19 vaccine update: Certain immunocompromised individuals eligible for second booster and amendments to Ministry of Health’s vaccine administration guide | Vaccine-preventable diseases |
| 2022-04-26 | CMOH Memo: Severe acute hepatitis of unknown origin in children (PDF, 157 KB) | Severe acute hepatitis |
| 2022-04-26 | COVID-19 vaccination update: Novovax (Nuvaxovid) | Vaccine-preventable diseases |
| 2022-04-13 | Clinician responsibilities in Adverse Event Following Immunization (AEFI) monitoring and reporting
| Vaccine-preventable diseases |
| 2022-04-08 | COVID-19 vaccine strongly recommended for high-risk populations | Vaccine-preventable diseases |
| 2022-04-07 | COVID-19 vaccine update: Fourth doses for additional populations (second booster) and Moderna primary series for 6 to 11 year olds with moderate to severe immunocompromise | Vaccine-preventable diseases |
| 2022-03-28 | Sodium in Sudbury and districts drinking water supplies | Levels of sodium in municipal drinking water supplies |
| 2022-03-03 | Public Health resuming routine immunization services | Vaccine-preventable diseases |
| 2022-02-18 | COVID-19 vaccine update: Booster doses for all individuals 12 to 17 years of age and updated vaccination timing following COVID-19 infection | Vaccine-preventable diseases |
| 2022-02-09 | COVID-19 vaccine update: Booster dose eligibility, new groups for a three-dose primary series, and booster dose timing following COVID-19 infection
Ministry of Health COVID-19 vaccine third dose recommendations February 7, 2022 (PDF, 316 KB) | Vaccine-preventable diseases |
| 2022-02-04 | COVID-19 vaccine update: Guidance for individuals vaccinated outside of Ontario or Canada | Vaccine-preventable diseases |
| 2022-01-18 | Updates regarding medical exemption and vaccination with COVID-19 vaccines following myocarditis (with or without pericarditis) | Vaccine-preventable diseases |
| 2022-01-15 | Changes to the management of COVID-19 cases, contacts and outbreaks in highest risk settings | Changes to COVID-19 Case and Contact Management |
| 2022-01-14 | COVID-19 vaccine update: Fourth doses for select populations | Vaccine-preventable diseases |
| 2022-01-10 | Public Health services disruption | Public Health Services |
| 2022-01-05 | Updated COVID-19 testing & case and contact management | Vaccine-preventable diseases |
| 2022-01-04 | Updates to medical exemptions for COVID-19 vaccine | Vaccine-preventable diseases |
| 2021-12-24 | Holiday greetings and advisement that rapid changes to COVID-19 case and contact management are underway | Changes to COVID-19 Case and Contact Management |
| 2021-12-17 | Updates to medical exemptions for COVID-19 vaccine | Vaccine-preventable diseases |
| 2021-12-17 | COVID-19 vaccine update: Recommendations on expanded booster dose eligibility to protect against Omicron variant | Vaccine-preventable diseases |
| 2021-12-06 | COVID-19 vaccine update: Recommendations on expanded booster dose and third dose eligibility for individuals aged 50+ | Vaccine-preventable diseases |
| 2021-11-29 | Call to action: Primary care provider support needed for routine immunization services | Vaccine-preventable diseases |
| 2021-11-23 | COVID-19 vaccine update: Pfizer-BioNTech Comirnaty COVID-19 vaccine now available for children aged 5 to 11 | Vaccine-preventable diseases |
| 2021-11-04 | COVID-19 vaccine update: Ministry of Health updates third dose recommendations | Vaccine-preventable diseases |
| 2021-10-20 | COVID-19 vaccine update: Expanded list of eligible medications for third doses of COVID-19 vaccine | Vaccine-preventable diseases |
| 2021-10-08 | COVID-19 vaccine update: Verifying immunosuppressive prescriptions for third doses, and expanded eligibility criteria for vulnerable elderly living in congregate settings | Vaccine-preventable diseases |
| 2021-10-01 | COVID-19 vaccine update: Pfizer-BioNTech Comirnaty® recommended for individuals aged 18 to 24 years | Vaccine-preventable diseases |
| 2021-10-01 | Influenza vaccine availability for the 2021/2022 season | Vaccine-preventable diseases |
| 2021-09-24 | Important change to passive tick surveillance in Ontario | Infectious diseases |
| 2021-09-22 | Update on criteria for medical exemption to COVID-19 vaccination | Vaccine-preventable diseases |
| 2021-09-17 | Vaccine certificate (passport) requirements and criteria for medical exemption | Vaccine-preventable diseases |
| 2021-09-16 | COVID-19 vaccine update: Recommendations on expanded third dose eligibility for moderately to severely immunocompromised individuals | Vaccine-preventable diseases |
| 2021-09-14 | Infection prevention and control key principles for clinical office practice | Infectious diseases |
| 2021-09-10 | Minimal Contact Intervention (MCI) protocol for COVID-19 vaccine; new vaccine hesitancy survey | Vaccine-preventable diseases |
| 2021-08-31 | COVID-19 vaccine update: Third dose rollout for select vulnerable populations | Vaccine-preventable diseases |
| 2021-08-20 | Adverse events following immunization guidance and recommendations | Vaccine-preventable diseases |
| 2021-08-20 | Treatment for Infectious Syphilis | Sexual health |
| 2021-08-18 | COVID-19 vaccination update: Policies for high-risk settings; third dose recommendations for vulnerable groups; youth born in 2009 now eligible. | Vaccine-preventable diseases |
| 2021-08-10 | Pfizer – BioNTech COVID-19 vaccine label to reflect very rare reports of Bell’s Palsy | Vaccine-preventable diseases |
| 2021-08-06 | Seeking support to improve vaccine uptake among vulnerable groups and priority populations | Vaccine-preventable diseases |
| 2021-08-05 | Outbreak of hepatitis A infections linked to frozen mangoes | Vaccine-preventable diseases |
| 2021-07-30 | Reports of Guillain-Barré Syndrome following adenovirus vector COVID-19 vaccines | Vaccine-preventable diseases |
| 2021-07-21 | Rotavirus vaccine product change | Vaccine-preventable diseases |
| 2021-07-02 | COVID-19 vaccine updates: Revised vaccine product monographs and accelerated dosing intervals for youth | Vaccine-preventable diseases |
| 2021-06-29 | Provincial Recommendations and Directive #5
Memorandum: Provincial Recommendations and Directive #5 (Ministry of Health) (PDF, 140 KB) | Vaccine-preventable diseases |
| 2021-06-24 | Updated recommendations on exceptions to extended dose intervals for COVID-19 vaccines
| Vaccine-preventable diseases |
| 2021-06-21 | Heterologous COVID-19 mRNA vaccine schedules and resources for health care providers
Q&A for Health Care Providers on mixed COVID-19 mRNA vaccine schedules (Ministry of Health) (PDF, 100 KB) | Vaccine-preventable diseases |
| 2021-06-18 | Reports of myocarditis and pericarditis after COVID-19 mRNA vaccines | Vaccine-preventable diseases |
| 2021-06-17 | Missed opportunities for vaccination: It is time to catch up | Vaccine-preventable diseases |
| 2021-06-13 | Accelerated dosing interval for AstraZeneca clients | Vaccine-preventable diseases |
| 2021-06-11 | Interchangeability of COVID-19 vaccines, AstraZeneca vaccine Q&A, and quick reference for second doses | Vaccine-preventable diseases |
| 2021-06-03 | Updated guidance on AstraZeneca second dose options
| Vaccine-preventable diseases |
| 2021-05-29 | Additional exceptions to the extended dose interval for the COVID-19 vaccine
| Vaccine-preventable diseases |
| 2021-05-25 | Information for individuals who received a first dose of the AstraZeneca COVID-19 vaccine | Vaccine-preventable diseases |
| 2021-05-21 | Guidance for employers managing workers with symptoms post COVID-19 vaccination | Vaccine-preventable diseases |
| 2021-05-15 | High-risk health care workers eligible to receive a second dose of the COVID-19 vaccine at a shortened interval | Vaccine-preventable diseases |
| 2021-05-14 | Immediate reporting of specific events following AstraZeneca/ COVISHIELD COVID-19 vaccines | Vaccine-preventable diseases |
| 2021-05-11 | Ontario pauses rollout and administration of AstraZeneca’s COVID-19 vaccine | Vaccine-preventable diseases |
| 2021-05-11 | COVID-19 vaccine additional exceptions to the extended dosing interval | Vaccine-preventable diseases |
| 2021-04-23 | Update: Pregnancy now considered highest-risk health condition; now eligible for vaccination | Vaccine-preventable diseases |
| 2021-04-20 | Administration of COVID-19 vaccine for essential Caregivers of individuals with highest and high-risk health conditions | Vaccine-preventable diseases |
| 2021-04-16 | Infection prevention and control for COVID-19 | Vaccine-preventable diseases |
| 2021-04-14 | COVID-19 vaccine dosing intervals, booking and PPE reminders | Vaccine-preventable diseases |
| 2021-04-14 | Administration of publicly funded COVID-19 vaccine in Ontario and Primary Care Clinics | Vaccine-preventable diseases |
| 2021-04-08 | Individuals with high-risk health conditions eligible for COVID-19 vaccine – assistance requested to advise patients | Vaccine-preventable diseases |
| 2021-04-01 | Additional COVID-19 vaccination opportunities for health care workers | Vaccine-preventable diseases |
| 2021-03-31 | Individuals with highest risk health conditions eligible for COVID-19 vaccine - assistance requested to advise patients | Vaccine-preventable diseases |
| 2021-03-23 | Guidance for prioritization of Phase 2 populations for COVID-19 vaccination
COVID-19: Guidance for prioritization of Phase 2 populations for COVID-19 vaccination (PDF, 6 MB)
| Vaccine-preventable diseases |
| 2021-03-22 | 80+ and chronic home care recipients can now book for COVID-19 vaccination | Vaccine-preventable diseases |
| 2021-03-15 | Centre for Effective Practice (CEP): COVID-19 vaccine resource centre | Vaccine-preventable diseases |
| 2021-03-05 | 80+ and chronic home care recipients can now pre-register for COVID-19 vaccination
| Vaccine-preventable diseases |
| 2021-03-01 | Health care workers can now pre-register for COVID-19 vaccination
| Vaccine-preventable diseases |
| 2021-02-19 | COVID-19 vaccine updates: Allergy information for Clinicians and documentation of verbal attestation for Clinic use (Re-release) | Vaccine-preventable diseases |
| 2021-02-18 | COVID-19 vaccine updates: Allergy information for Clinicians and documentation of verbal attestation for Clinic use
| Vaccine-preventable diseases |
| 2021-02-10 | Primary Care Registry (Re-release) | Vaccine-preventable diseases |
| 2021-02-08 | Primary Care Registry | Vaccine-preventable diseases |
| 2020-12-16 | Updated COVID-19 guidance for contact identification and management relating to a health care worker | Infectious diseases |
| 2020-12-14 | COVID-19 vaccines & Provincial rollout
| Vaccine-preventable diseases |
| 2020-12-04 | Additional Flu vaccine supply: FluMist® Quadrivalent Intra-nasal | Vaccine-preventable diseases |
| 2020-11-27 | Update: Flu vaccine | Vaccine-preventable diseases |
| 2020-11-20 | New respiratory outbreak testing prioritization protocol | Infectious diseases |
| 2020-11-20 | Specimen collection kits for Chlamydia trachomatis and Neisseria gonorrhoeae (NAAT) shortage | Sexual health |
| 2020-11-09 | Continued shortage of Erythromycin Ophthalmic ointment | Infectious diseases |
| 2020-10-21 | *New* Infection prevention and control assessment checklist for primary care, specialty, and walk-in clinics during COVID-19
Infection prevention and control assessment for primary care, specialty and walk-in clinics during COVID-19 (PDF, 884 KB)
| Infectious diseases
|
| 2020-10-02 | Guidance for COVID-19 for children in School and Child Care | Updated COVID-19 guidance for children in school and child care |
| 2020-09-30 | Universal Influenza Immunization Program implementation package | Infectious diseases |
| 2020-09-21 | Guidance for COVID-19 following school reopening | Infectious diseases |
| 2020-09-17 | Updated guidance for immunization services during COVID-19 | Vaccine-preventable diseases |
| 2020-09-17 | Influenza vaccine updates for the 2020/21 season | Vaccine-preventable diseases |
| 2020-09-08 | Guidance on the delivery of influenza vaccine during COVID-19 | Vaccine-preventable diseases |
| 2020-08-17 | Rotavirus vaccine reminder
| Infectious diseases |
| 2020-07-24 | Chlamydia treatment
Chlamydia treatment (PDF, 200 KB) | Sexual health |
| 2020-06-30 | COVID-19 Guidance: Primary care providers in a community setting
| Infectious diseases |
| 2020-04-29 | Guidance for immunization service providers during COVID-19
Guidance for immunization service providers during COVID-19 (PDF, 205 KB) | Infectious diseases |
| 2020-04-26 | Primary care guidance update (COVID-19)
Ministry of Health, Primary care guidance update (PDF, 91.7 KB) | Infectious diseases |
| 2020-04-11 | Targeted surveillance for COVID-19 | Infectious diseases |
| 2020-03-26 | Updated COVID-19 guidance and testing sites
COVID-19 Quick reference Public Health guidance on testing and clearance (PDF, 311 KB) | Updated COVID-19 guidance and testing sites |
| 2020-03-21 | Communication with Public Health
Primary care COVID-19 guidance 2020-03-20 (PDF, 375 KB) | Communication with Public Health and primary care guidance update |
| 2020-03-17 | COVID‐19 – healthcare workers returning from travel and criteria for accessing testing | Infectious diseases |
| 2020-03-16 | Updated COVID-19 recommendations | Infectious diseases |
| 2020-03-10 | First confirmed case of COVID-19 | Infectious diseases |
| 2020-01-24 | Update: Novel Coronavirus (2019-nCoV)
Association Chief Medical Officer of Health Letter, January 23, 2020 (PDF, 278 KB)
Case Definition 2019-nCoV, January 23, 2020 (PDF, 278 KB) | Infectious diseases |
| 2020-01-22 | Resources to Manage Novel Coronavirus Identified in China | Infectious diseases |
| 2020-01-10 | Vaccination requirements for school attendance
| Vaccine-preventable diseases |
| 2020-01-03 | Second Case of Hepatitis A Exposure at Real Canadian Superstore, 1485 Lasalle Blvd., Sudbury | Infectious diseases |
| 2019-12-17 | Hepatitis A Exposure at Real Canadian Superstore, 1485 Lasalle Blvd., Sudbury | Infectious diseases |
| 2019-12-02 | Administration of Influenza Vaccine
English (PDF, 148 KB)
Administration of Influenza Vaccine CMOH Letter to HCP
French (PDF, 148 KB)
Administration of Influenza Vaccine CMOH Letter to HCP
| Vaccine-preventable diseases |
| 2019-10-02 | Influenza Surge Planning: Recommendations for Health Care Providers
English (PDF, 102 KB)
Seasonal Influenza Update CMOH Memo FINAL 2019-09-25 shared
French (PDF, 103 KB)
Seasonal Influenza Update CMOH Memo FINAL 2019-09-25 shared
| Vaccine-preventable diseases |
| 2019-08-13 | Locally-acquired cyclosporiasis in Ontario
| Infectious diseases |
| 2019-07-29 | Rabies vaccine and immunoglobulin shortages | Vaccine-preventable diseases |
| 2019-05-22 | Enhanced Surveillance for Pertussis (whooping cough) | Vaccine-preventable diseases |
| 2019-05-14 | Infectious Syphilis Cases Increasing Locally | Sexual health |
| 2019-05-14 | Extensively Drug Resistant S. Typhi in Ontario Travellers Returning from Pakistan | Vaccine-preventable diseases |
| 2019-04-24 | Increasing Influenza A (H3N2) Activity in the Public Health Sudbury & Districts area | Vaccine-preventable diseases |
| 2019-03-25 | Shortage of erythromycin ophthalmic ointment
Screening Algorithm (PDF, 526 KB)
Response to Lab Results Algorithm (PDF, 522 KB)
| Vaccine-preventable diseases |
| 2019-03-07 | Provincial Supply of Zostavax® II Vaccine | Vaccine-preventable diseases |
| 2019-01-24 | Influenza Vaccine Availability in the Public Health Sudbury & Districts Area
| Vaccine-preventable diseases |
| 2019-01-14 | Ophthalmia Neonatorum and Erythromycin Ophthalmic Ointment Shortage | Vaccine-preventable diseases |
| 2018-12-27 | Influenza updates including testing availability in the Public Health Sudbury & Districts area | Vaccine-preventable diseases |
| 2018-11-26 | Discontinuation of the Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis (Td-IPV) Vaccine | Vaccine-preventable diseases |
| 2018-11-20 | Influenza vaccines for seniors during the 2018/19 influenza season | Vaccine-preventable diseases |
| 2018-10-23 | Acute flaccid myelitis – Summary and current Ontario situation | Infectious diseases |
| 2018-10-05 | Listeriosis outbreak
| Infectious diseases |
| 2018-10-04 | Universal Influenza Immunization Program (UIIP): Influenza Vaccine Product Availability for the 2018/19 Season
| Vaccine-preventable diseases |
| 2018-07-30 | Vaccine recall in China | Vaccine-preventable diseases |
| 2018-07-17 | Rotavirus vaccine changes
| Vaccine-preventable diseases |
| 2018-07-13 | Locally-acquired cyclosporiasis in Ontario
| Infectious diseases |
| 2018-07-04 | Enhanced Surveillance for Pertussis (whooping cough)
| Vaccine-preventable diseases |
| 2018-05-30 | Updates to the Health Protection and Promotion Act (HPPA)
Diseases of Public Health Significance (PDF, 364 KB)
| Immunization
Infectious diseases
Vaccine-preventable diseases
|
| 2018-03-20 | Healthy Growth Initiative
What is BORN? (PDF, 519 KB) | Healthy Growth Initiative |
| 2018-03-09 | Varicella Activity Among Post-Secondary Students | Vaccine-preventable diseases |
| 2018-01-29 | Use of quadrivalent influenza vaccine (QIV) during the remainder of the 2017/18 influenza season | Vaccine-preventable diseases |
| 2017-11-06 | Update on Provincial Vaccine Preventable Disease Outbreaks and Recommended Vaccines
| Vaccine-preventable diseases |
| 2017-11-03 | First Case of Confirmed Influenza Reported in the Sudbury & District Health Unit Area
| Vaccine-preventable diseases |
| 2017-10-06 | DTaP-IPV being replaced with DTaP-IPV-Hib
| Vaccine-preventable diseases |
| 2017-09-17 | Enhanced Surveillance for Mumps | Vaccine-preventable diseases |
| 2017-09-09 | Cluster of Pediatric Blastomycosis Cases
| Infectious diseases |
2017-08-18
| Lyme disease (letter from the Minister of Health and Long-Term Care)
English (PDF, 99 KB)
Lyme Disease Letter from MOHLTC
French (PDF, 138 KB)
Lyme Disease Letter from MOHLTC | Infectious diseases |
| 2017-07-14 | Provincial Cyclospora outbreak | Infectious diseases |
| 2017-04-04 | Measles Activity in Toronto and Peel | Vaccine-preventable diseases |
| 2017-03-09 | Spectinomycin Shortage | Sexual health |
| 2016-11-23 | First Case of Confirmed Influenza Reported in the Sudbury & District Health Unit Area | Vaccine-preventable diseases |
| 2016-11-07 | Antiviral medications for the prevention and treatment of seasonal influenza | Vaccine-preventable diseases |
| 2016-11-01 | 2016/17 Influenza vaccination recommendations for children | Vaccine-preventable diseases |
| 2016-10-06 | Reminder re: publicly funded shingles immunization program | Vaccine-preventable diseases |
| 2016-09-15 | Publicly funded shingles immunization program | Vaccine-preventable diseases |
| 2016-06-24 | Enhanced surveillance for pertussis (whooping cough) | Vaccine-preventable diseases |
| 2016-04-23 | Multi-province hepatitis A outbreak linked to frozen berries | Vaccine-preventable disease |
| 2016-04-18 | Multi-province hepatitis A outbreak linked to frozen berries | Vaccine-preventable disease |
| 2016-04-16 | Multi-province hepatitis A outbreak linked to frozen berries | Vaccine-preventable diseases |
| 2016-02-04 | Zika virus infection: laboratory testing information (Public Health Ontario) | Infectious diseases |
| 2015-11-30 | Influenza confirmed in the Sudbury & District Health Unit area | Vaccine-preventable diseases |
| 2015-11-12 | Syrian refugee crisis | Memorandum |
| 2015-11-09 | Administration of Flumist® (Pharmacists) | Immunization |
| 2015-11-06 | Confirmed case of Tularemia in Sudbury District | Infectious diseases |
| 2015-10-09 | Universal influenza immunization program materials | Immunization |
| 2015-09-15 | Surveillance information for Enterovirus D68 | Respiratory |
| 2015-08-19 | Memo: Meningitis World Scout Jamboree in Japan August 19, 2015 (PDF, 83 KB)
Meningococcal Fact Sheet (PDF, 181 KB)
Meningococcal Fact Sheet (French) (PDF 182 KB) | Vaccine-preventable diseases |
| 2015-06-24 | PHO Rounds: EV-D68 in Ontario: What happened in 2014 and what’s next? | PHO Rounds: Microbiology |
| 2015-06-04 | Temporary shortage of DTaP-IPV (Infanrix®-IPV or Quadracel®) | Immunization |
| 2015-04-30 | Updated 2015 publicly funded immunization schedules for Ontario | Immunization |
| 2015-03-24 | Immunization requirements for school attendance | Immunization |
| 2015-02-06 | Measles vaccination schedule details | Vaccine-preventable diseases |
| 2015-02-04 | Measles activity in Toronto | Vaccine-preventable diseases |
| 2015-02-01 | Confirmed case of Invasive Group A Streptococcal Infection in Chapleau | Vaccine-preventable diseases |
| 2015-01-29 | Hepatitis A exposure at Casey's Bar & Grill, 1070 Kingsway Boulevard, Sudbury | Vaccine-preventable diseases |
| 2015-01-14 | Influenza season: antiviral supply and ordering | Vaccine-preventable diseases |
| 2015-01-07 | Increased influenza activity in Sudbury & District Health Unit area | Vaccine-preventable diseases |
| 2014-12-12 | 2014-2015 influenza season | Vaccine-preventable diseases |
